Subsequently, Yuan et al. demonstrated that leptin levels were increased in cervix carcinoma cells in a dose-dependent fashion and this correlated with increased protein and mRNA levels of c-myc, which is a well-known oncogene. The gene discussed is LEP; the disease is cervical carcinoma.